The COVID-19 Global Rheumatology Alliance (GRA) was formed to curate and disseminate knowledge to advance rheumatology care in the pandemic. This dissertation talk will present methods using the GRA provider registry data to study COVID-19 outcomes in people receiving immunomodulatory medications, identify risk factors for severe COVID-19, and understand environmental and societal drivers of global disparities in COVID-19 outcomes in people with rheumatic disease.
Speaker: Zara Izadi, MPharm, MAS, PhD Candidate, Epidemiology and Translational Science
Registry: http://tiny.cc/EpiBioEmailList